Enovis Corp (FRA:C520)
€ 21.8 +1.4 (+6.86%) Market Cap: 1.30 Bil Enterprise Value: 2.51 Bil PE Ratio: 0 PB Ratio: 1.00 GF Score: 64/100

Q2 2024 Enovis Corp Earnings Call Transcript

Aug 07, 2024 / 12:00PM GMT
Release Date Price: €38.2 (-6.83%)

Key Points

Positve
  • Enovis Corp (ENOV) reported a 23% year-over-year growth in the second quarter of 2024, with a 5% growth on a comparable basis.
  • The company expanded its adjusted EBITDA margins by 190 basis points, reflecting productivity improvements and the impact of the Lima acquisition.
  • Enovis Corp (ENOV) achieved significant progress in the integration of Lima, with no major unforeseen issues and a detailed multiyear plan in place.
  • The US Recon business showed resilience with 1% growth, including 2% growth in US extremities and 2% in hips and knees, despite integration-related impacts.
  • The company reported strong international growth, with a 14% increase in Recon revenue in resilient markets.
Negative
  • The US Recon business experienced slower growth due to integration-related dissynergies, impacting growth by an estimated 3% to 4% in the first half of the year.
  • US hips have been under pressure, with growth rates below historical trends due to integration impacts and shifting market needs.
  • The US shoulder business faced temporary headwinds, including direct overlap with Lima and delays in new product launches.
  • The company experienced a 3% comparable growth in P&R, reflecting a stable market environment but lower than expected growth.
  • Enovis Corp (ENOV) adjusted its revenue guidance to reflect the divestiture impact, indicating a tighter range but not an increase in overall growth expectations.
Operator

Good day and welcome to the Enovis second-quarter 2024 earnings call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Kyle Rose, Vice President of Investor Relations. Please go ahead.

Kyle Rose
Enovis Corp - Vice President - Investor Relations

Good morning, everyone, and thank you for joining us today for our second quarter 2024 results conference call. I'm Kyle Rose, Vice President of Investor Relations. Joining me on the call today are Matt Trerotola, Chair and Chief Executive Officer; and Ben Berry, Chief Financial Officer. Our earnings release was issued earlier this morning and is available in the Investors section of our website, enovis.com. We will be using a slide presentation in today's call, which can also be found on our website. Both the audio and the presentation of the call will be archived on the website later today.

During the call, we'll be making some forward-looking statements about our beliefs and estimates regarding future events and results. These forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot